ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-12-11 |   Pages: 200+ |   Report ID: WR-2024-12-11-201080 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Adeno Associated Virus Vector Manufacturing Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET

7.1 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA ADENO ASSOCIATED VIRUS VECTOR MANUFACTURING MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Bayer AG

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 uniQure

16.3 Oxford Biomedica

16.4 Novartis AG

16.5 bluebird bio

16.6 AAVexis

16.7 REGENXBIO

16.8 Sanofi

16.9 Takara Bio

16.10 Janssen Biotech, Inc.

16.11 Bamboo Therapeutics

16.12 AskBio Therapeutics LLC

16.13 Pfizer

16.14 Solid Biosciences Inc.

16.15 Astellas Pharma

16.16 Roche

16.17 Audentes Therapeutics

16.18 WuXi AppTec

16.19 BioMarin Pharmaceutical

16.20 YPOSKESI

16.21 Sarepta Therapeutics

16.22 GenScript

16.23 LifeSpan BioSciences, Inc.

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Vector Type
Self-complementary AAV Vectors
Single-stranded AAV Vectors
Hybrid AAV Vectors

By Application
Gene Therapy
Vaccine Development
Targeted Drug Delivery
Tissue Engineering
Cell Therapy

By Production Scale
Small-scale Manufacturing
Medium-scale Manufacturing
Large-scale Manufacturing

By Purification Method
Chromatography
Ultrafiltration
Nanoprecipitation

By Therapeutic Area
Genetic Disorders
Infectious Diseases
Neurological Disorders
Hematological Diseases
Ophthalmic Disorders

Companies

Bayer AG
uniQure
Oxford Biomedica
Novartis AG
bluebird bio
AAVexis
REGENXBIO
Sanofi
Takara Bio
Janssen Biotech, Inc.
Bamboo Therapeutics
AskBio Therapeutics LLC
Pfizer
Solid Biosciences Inc.
Astellas Pharma
Roche
Audentes Therapeutics
WuXi AppTec
BioMarin Pharmaceutical
YPOSKESI
Sarepta Therapeutics
GenScript
LifeSpan BioSciences, Inc.

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.